123 related articles for article (PubMed ID: 33653978)
1. FOS Rearrangement and Expression in Cementoblastoma.
Lam SW; Cleven AHG; Briaire-de Bruijn IH; Schreuder WH; Kroon HM; Savci-Heijink DC; Suurmeijer AJH; Szuhai K; Bovée JVMG; Baumhoer D
Am J Surg Pathol; 2021 May; 45(5):690-693. PubMed ID: 33653978
[TBL] [Abstract][Full Text] [Related]
2. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
[TBL] [Abstract][Full Text] [Related]
3. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.
Lam SW; Cleven AHG; Kroon HM; Briaire-de Bruijn IH; Szuhai K; Bovée JVMG
Virchows Arch; 2020 Mar; 476(3):455-463. PubMed ID: 31768625
[TBL] [Abstract][Full Text] [Related]
4. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
Saba KH; Cornmark L; Hofvander J; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Foijer F; Staaf J; Brosjö O; Sumathi VP; Lam SW; Szuhai K; Bovée JV; Kovac M; Baumhoer D; Styring E; Nord KH
J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935
[TBL] [Abstract][Full Text] [Related]
5. Recurrent rearrangements of FOS and FOSB define osteoblastoma.
Fittall MW; Mifsud W; Pillay N; Ye H; Strobl AC; Verfaillie A; Demeulemeester J; Zhang L; Berisha F; Tarabichi M; Young MD; Miranda E; Tarpey PS; Tirabosco R; Amary F; Grigoriadis AE; Stratton MR; Van Loo P; Antonescu CR; Campbell PJ; Flanagan AM; Behjati S
Nat Commun; 2018 Jun; 9(1):2150. PubMed ID: 29858576
[TBL] [Abstract][Full Text] [Related]
6. New kids on the block:
Cordier F; Creytens D
J Clin Pathol; 2023 Nov; 76(11):721-726. PubMed ID: 37553246
[No Abstract] [Full Text] [Related]
7. Case report: a pediatric case of cementoblastoma with histologic and radiographic features of an osteoblastoma and osteosarcoma.
Bilodeau E; Collins B; Costello B; Potluri A
Head Neck Pathol; 2010 Dec; 4(4):324-8. PubMed ID: 20737258
[TBL] [Abstract][Full Text] [Related]
8. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract][Full Text] [Related]
9. Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
Ameline B; Nathrath M; Nord KH; de Flon FH; Bovée JVMG; Krieg AH; Höller S; Hench J; Baumhoer D
Mod Pathol; 2022 Sep; 35(9):1204-1211. PubMed ID: 35347251
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
11. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas.
Bishop JA; Alaggio R; Zhang L; Seethala RR; Antonescu CR
Am J Surg Pathol; 2015 Sep; 39(9):1267-74. PubMed ID: 26034869
[TBL] [Abstract][Full Text] [Related]
12. Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.
Huang SC; Zhang L; Sung YS; Chen CL; Krausz T; Dickson BC; Kao YC; Agaram NP; Fletcher CD; Antonescu CR
Am J Surg Pathol; 2015 Oct; 39(10):1313-21. PubMed ID: 26135557
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of 6 cases of epithelioid osteoblastoma of the jaws with immunoexpression analysis of FOS and FOSB.
Pereira TDSF; Andrade BAB; Romañach MJ; Pereira NB; Gomes CC; Mariz BALA; Almeida OP; Agostini M; van Heerden WFP; Carlos R; Gomez RS; Fonseca FP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):191-199. PubMed ID: 32482537
[TBL] [Abstract][Full Text] [Related]
14. Recurrent FOS rearrangement in proliferative fasciitis/proliferative myositis.
Makise N; Mori T; Motoi T; Shibahara J; Ushiku T; Yoshida A
Mod Pathol; 2021 May; 34(5):942-950. PubMed ID: 33318581
[TBL] [Abstract][Full Text] [Related]
15. Cementoblastoma and osteoblastoma: a comparison of histologic features.
Slootweg PJ
J Oral Pathol Med; 1992 Oct; 21(9):385-9. PubMed ID: 1432731
[TBL] [Abstract][Full Text] [Related]
16.
Panagopoulos I; Gorunova L; Lobmaier I; Andersen K; Kostolomov I; Lund-Iversen M; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2020; 17(2):161-168. PubMed ID: 32108038
[TBL] [Abstract][Full Text] [Related]
17. Benign cementoblastoma. Case report.
Mogi K; Belal E; Kano A; Otake K
Aust Dent J; 1996 Feb; 41(1):9-11. PubMed ID: 8639125
[TBL] [Abstract][Full Text] [Related]
18. Cementoblastoma: report of case.
Farman AG; Köhler WW; Nortjé CJ; Van Wyk CW
J Oral Surg; 1979 Mar; 37(3):198-203. PubMed ID: 283220
[No Abstract] [Full Text] [Related]
19. Benign cementoblastoma. A review and five new cases.
Ulmansky M; Hjørting-Hansen E; Praetorius F; Haque MF
Oral Surg Oral Med Oral Pathol; 1994 Jan; 77(1):48-55. PubMed ID: 8108097
[TBL] [Abstract][Full Text] [Related]
20. Human cementum tumor cells have different features from human osteoblastic cells in vitro.
Arzate H; Alvarez-Pérez MA; Aguilar-Mendoza ME; Alvarez-Fregoso O
J Periodontal Res; 1998 Jul; 33(5):249-58. PubMed ID: 9777591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
